No Data
No Data
No Data
No Data
No Data
Achilles Therapeutics Is Maintained at Buy by Chardan Capital
Achilles Therapeutics Is Maintained at Buy by Chardan Capital
Dow JonesApr 5 18:47
Achilles Therapeutics Price Target Cut to $6.00/Share From $11.00 by Chardan Capital
Achilles Therapeutics Price Target Cut to $6.00/Share From $11.00 by Chardan Capital
Dow JonesApr 5 18:47
Achilles Therapeutics Cut to Neutral From Overweight by Piper Sandler
Achilles Therapeutics Cut to Neutral From Overweight by Piper Sandler
Dow JonesApr 5 18:43
Piper Sandler Downgrades Achilles Therapeutics to Neutral, Lowers Price Target to $2
Piper Sandler analyst Joseph Catanzaro downgrades Achilles Therapeutics (NASDAQ:ACHL) from Overweight to Neutral and lowers the price target from $8 to $2.
BenzingaApr 5 18:32
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of STAAR Surgical Company (NASDAQ:STAA) rose sharply during Thursday's session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%
BenzingaApr 5 01:21
BRNS, UPC and KWE Among Mid-day Movers
Seeking AlphaApr 5 01:06
No Data
No Data